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Abstract 
Nesprins (nuclear envelope spectrin repeat proteins) are a family of multi-isomeric 
scaffolding proteins. Nesprins form the LInker of Nucleoskeleton-and-Cytoskeleton (LINC) 
complex with SUN (Sad1p/UNC84)-domain containing proteins at the nuclear envelope (NE), in 
association with lamin A/C and emerin, linking the nucleoskeleton to the cytoskeleton. The LINC 
complex serves as both a physical linker between the nuclear lamina and the cytoskeleton and a 
mechanosensor. The LINC complex has a broad range of functions and is involved in maintaining 
nuclear architecture, nuclear positioning and migration and also modulating gene expression. Over 
80 disease related variants have been identified in SYNE-1/2 (nesprin-1/2) genes, which result in 
muscular or central nervous system (CNS) disorders including autosomal dominant Emery–
Dreifuss muscular dystrophy (EDMD), dilated cardiomyopathy (DCM) and autosomal recessive 
cerebellar ataxia type 1 (ARCA1). To date, 17 different nesprin mouse lines have been established 
to mimic these nesprin-related human diseases, which have provided valuable insights into the 
roles of nesprin and its scaffold LINC complex in a tissue specific manner. In this review, we 
summarise the existing nesprin mouse models, compare their phenotypes and discuss the potential 
mechanisms underlying nesprin-associated diseases. 
 
INTRODUCTION 
Nesprins (nuclear envelope spectrin repeat proteins) are the latest identified members of 
the spectrin repeat (SR) containing protein family [1]. To date, six genes encoding for different 
KASH domain containing proteins named as nesprins-1, -2, -3, -4, Lymphoid-restricted membrane 
protein (LRMP) and KASH5 have been identified in mammals [1-6].  
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Nesprin-1 and -2 are encoded by synaptic nuclear envelope (SYNE)-1 and -2 genes. The 
longest isoforms of nesprin-1 and -2  are the second (~1MDa) and third (~800kDa) largest proteins 
in man [1]. The general structure of these proteins comprises of an evolutionarily conserved 
Klarsicht/ANC-1/Syne Homology (KASH) domain at the C-terminus that targets nesprin family 
members to the nuclear envelope (NE); a central rod domain containing multiple SRs that mediate 
protein-protein interactions; and paired Calponin Homology (CH) domains at the N-terminus, also 
known as the actin binding domain (ABD) that binds to filamentous actin (F-actin) [1, 2]. Nesprin-
1/2 have diverse isoforms, which vary in length and differ in domain composition due to extensive 
alternative transcription initiation, termination and splicing [7] (for an extensive review of nesprin-
1/2 isoforms, we refer readers to [8]). Giant nesprin-1/2 isoforms are ubiquitously expressed, in 
particular nesprin-1 giant is enriched in vascular smooth muscle, while smaller nesprin-1/2 
isoforms, such as nesprin-1α2, 2α1 and 2Ɛ2, are specifically expressed in skeletal and cardiac muscle 
[1, 9, 10]. Nesprin-1/2 localise at either side of the NE through their KASH domains. Smaller 
nesprin-1/2 isoforms interact with lamin A/C, emerin and nucleoplasmic domain of Sad1p/UNC84 
(SUN) domain containing proteins SUN1/2 via their C-terminal SRs at the inner nuclear membrane 
(INM) [2, 11-13], however, it remains unclear how INM localisation is established. Nesprin-1/2 
giant isoforms localise at the outer nuclear membrane (ONM) and form the LInker of 
Nucleoskeleton-and-Cytoskeleton (LINC) complex via associations between their KASH domains 
and the SUN-domains of SUN1/2 in the perinuclear space (PNS) [14, 15]. The LINC complex 
tethers the NE to cytoskeletal elements including actin filaments and microtubule (MT) network 
[16-19]. This molecular linking network is pivotal in regulating nuclear integrity, maintaining 
nuclear-cytoskeleton coupling, participating in mechanotransduction, nuclear migration and 
positioning especially in muscle cell differentiation [2, 8, 17, 18, 20, 21].  
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Nesprin-3, -4, LRMP and KASH5 are encoded by SYNE-3, -4, LRMP and KASH5 genes and 
are much smaller than giant nesprin-1/2. They contain the KASH domain at the C-terminus and 
lack the N-terminal CH domains [3, 4, 6]. Nesprin-3 links the nucleus to intermediate filaments 
(IFs) via an interaction with plectin and regulates cell morphology, perinuclear cytoskeletal 
architecture and cell polarisation [3, 22, 23]. Differing from the ubiquitously expressed nesprin-
1/2/3, nesprin-4 is predominately expressed in epithelial cells, KASH5 is limited to meiotic cells 
while LRMP is rich in zebrafish zygotes and also expressed in the taste bud cells of the tongue in 
mammals [4, 6, 24, 25]. Nesprin-4, KASH5 and LRMP are involved in the MT associated LINC 
complex formation and function. Nesprin-4 recruits kinesin-1 to the NE and is involved in MT-
dependent nuclear positioning [4]. KASH5 participates in MT-driven telomere movement and 
chromosome pairing during mammalian meiosis, whereas LRMP mediates centrosome-nuclear 
attachment in zebrafish zygotes by associating with the MT-dynein/dynactin complex [24, 26].  
The ability of nesprin family members to link the nucleus with different cytoskeletal 
elements has led to the assumption that they primarily function as nucleoskeleton and cytoskeleton 
linkers. Intriguingly, many nesprin-1/2 isoforms that lack KASH domains exist and localise to 
various sub-cellular compartments, such as the sarcomere, sarcoplasmic reticulum, mitochondria, 
focal adhesions, Golgi and promyelocytic leukemia (PML) bodies, suggesting that nesprins 
possess additional functions [2, 7, 27, 28]. So far, over 80 disease associated variants, have been 
identified in SYNE-1/2 genes, which result in muscular or central nervous system (CNS) disorders 
including autosomal dominant Emery–Dreifuss muscular dystrophy (EDMD), dilated 
cardiomyopathy (DCM) and autosomal recessive cerebellar ataxia type 1 (ARCA1) [12, 29-37]. 
To elucidate the roles of nesprin mutations in pathogenesis of these diseases, 17 different 
nesprin mouse lines have been established and characterised, providing valuable insights into the 
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roles of nesprins and the LINC complex in different tissues (Figure 1, Table 1). In this review, we 
summarise all the existing nesprin mouse models into two categories: 1) nesprin-1/2 mouse models 
with skeletal and cardiac muscle phenotypes and 2) all other nesprin mouse models. We 
specifically focus on the cardiac and skeletal muscle defects in nesprin-1/2 mouse models and 
discuss the potential mechanisms underlying nesprin-associated diseases. 
 
NESPRIN-1/2 MOUSE MODELS WITH MUSCLE DISORDERS 
A nesprin mouse model with both skeletal and cardiac muscle disorders 
Nesprin-1 KASH Knockout (KO)①  
 The only nesprin mouse model that demonstrated both EDMD and DCM-like phenotypes 
was generated via global targeted deletion of the last exon of Syne-1 gene leading to removal of 
the last two exons that included the KASH domain in Prof. McNally’s lab, we renamed this mouse 
model as Nesprin-1 KASH KO①[29, 38]. The KASH1 KO① pups had a high perinatal mortality 
(49%) due to un-inflated lungs causing respiratory failure [38]. Surviving litters exhibited EDMD 
and DCM-like phenotypes, including hind limb weakness, abnormal gaits, kyphoscoliosis, muscle 
pathology, conduction defects (CD) and left ventricle (LV) systolic dysfunction [38]. The surface 
electrocardiogram (ECG) showed CD presented earlier in atria than ventricle and reduced LV 
fractional shortening, which was similar to observations described in patients with DCM and 
conduction system defects [29, 39]. 
 Cardiomyocytes (CMs) derived from KASH1 KO① mice displayed elongated nuclear 
morphology, large invaginations of the NE and reduced levels of heterochromatin [29]. Reduced 
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muscle fibre size accompanied with centralised nuclei was also evident in skeletal muscle biopsies, 
indicating defective nuclear positioning [38]. Interactions between nesprin-1 and SUN2 were 
disrupted, although lamin A/C, emerin and SUN2 remained staining at the NE [38]. The major 
limitation for this mouse model was that the additional 61 amino acid insertion replaced the KASH 
domain in KASH-containing nesprin-1 mutants. This fusion potentially created dominant negative 
(DN) nesprin-1 constructs that might contribute to the muscle phenotypes.  
 
Nesprin-1/2 mouse model with cardiac muscle disorders 
Nesprin-1/2 C-terminal double KO (DKO) 
The nesprin-1/2 C-terminal DKO mouse model was independently generated in Prof. 
Chen’s lab, by crossing two previously established mouse lines: cardiac specific nesprin-1 C-
terminal KO mice and global nesprin-2 C-terminal KO mice [40]. DKO hearts were theoretically 
ablated of all nesprin-1 and -2 isoforms containing the C-terminal SR region with or without the 
KASH domain. This included the muscle specific isoforms nesprin-1α2, nesprin-2α1 and nesprin-
2Ɛ2. No overt cardiac and skeletal muscle dysfunction phenotypes were reported in either cardiac 
specific nesprin-1 deletion or global nesprin-2 deletion mice previously [40]. However, DKO mice 
displayed early onset cardiomyopathy: LV wall thickness and fractional shortening was decreased 
at 10 weeks and deteriorated over time [40]. Increased fibrosis and apoptosis was detected in DKO 
heart tissue and expression of foetal genes ANP, βMHC and profibrotic genes procollagen 1α1, 
3α1 were also increased [40].  
Similar to the nesprin-1 KASH KO① mice, the CMs derived from this DKO mice also 
showed morphologically altered nuclei [40]. However, the LINC complex associated components, 
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lamin A/C and emerin, were mis-localised from the NE, although their expression levels remained 
unchanged in the DKO mice, indicating the compromised LINC complex was caused by defects 
in the localisation of these proteins rather than changes in expression levels [40]. Furthermore, 
when mechanical load was applied to DKO and WT CMs, there were dramatically upregulated 
biomechanical responsive genes including egr-1, iex-1, c-jun, c-fos and c-myc in WT CMs, while 
expression of these genes was abrogated in DKO CMs [40]. These data demonstrate that nesprin-
1/2 play essential roles in cardiac physiology, maintenance and responsiveness to biomechanical 
load.  
 
Nesprin-1/2 mouse models with skeletal muscle disorders 
Nesprin-1 KASH DN/KO②, Nesprin-2 KASH DN/KO and Nesprin-1/2 KASH DKO 
Five KASH1 and/or KASH2 domain mouse lines were generated in Professor Han’s lab to 
investigate nesprin functions in striated muscle [41, 42]. A striated muscle specific nesprin-1 
KASH DN mouse line was generated by using a muscle creatine kinase (MCK) promoter that 
enabled highly preferential expression of nesprin-1 C-terminal 344 amino acids including the last 
SR and KASH domain in skeletal and cardiac muscle [41, 43, 44]. Utilising the same strategy, 
striated muscle specific nesprin-2 KASH DN mice were also established [42]. Of note, although 
this strategy was designed to target skeletal and cardiac muscle, smooth muscle may also have 
been affected and contribute to this phenotype. However, this remains to be tested.  In addition, 
global KASH1 KO② and KASH2 KO mice were generated via targeted deletion of the last one 
(Syne-1) and two (Syne-2) exons respectively, which encode for the KASH domains of Syne-1 and 
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Syne-2 genes [42]. The global nesprin-1/2 KASH DKO line was generated by crossing the KASH1 
KO② with KASH2 KO [42].  
All KO/DN strains were viable, with the exception of  the KASH1/2 DKO litters that died 
after birth due to respiratory failure, which was suggested to be likely secondary to the CNS 
development defect [42, 45]. Defects in other organs/tissues that are rich in nesprin-1/2 isoforms 
could also potentially contribute to this lethality. For example: the function of smooth muscle 
(containing mainly nesprin-1 giant isoform) and/or diaphragm (skeletal muscle containing mainly 
nesprin-1α2 and nesprin-2α1) could be perturbed and lead to impaired dilation of the bronchi and 
abnormal volume/pressure changes of thoracic cavity during respiration [9, 46, 47]. However, no 
overt cardiac or skeletal muscular-related symptoms were reported in the KASH1/2 DKO mice 
[41, 42].  
Nesprin-1 plays major roles in nuclear migration and myogenesis. Nuclear positioning 
defects in muscle fibres were also prevalent in skeletal muscle biopsies derived from these mice. 
The KASH1 KO② and KASH1/2 DKO displayed the most severe nuclear positioning phenotypes 
with the total loss of synaptic nuclei and clustered non-synaptic nuclei [41, 42]. The difference in 
severity between the strains is potentially explained because a low level of endogenous nesprin-1 
remained at the NE in KASH1/KASH2 DN mice, whereas nesprin-1 is absent from the NE in the 
cells derived from the KASH1 KO② or KASH1/2 DKO. [41, 42]. In contrast, nuclei were properly 
anchored in skeletal muscle derived from KASH2 KO mice, suggesting nesprin-2 KASH 
containing isoforms do not participate in myonuclear positioning [42]. Nonetheless, KASH2 may 
be more critical in retinal and neuronal development as there were retina and learning/memory 
defects in KASH2 KO mice (further discussion refer to the section of ‘OTHER NESPRIN MOUSE 
MODELS’) [45, 48].  
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Nesprin-1 C-terminal KO 
Global Nesprin-1 C-terminal KO line was established by floxed deletion of the 16th exon 
of Syne-1 gene and resulted in a premature stop codon at the 13th exon (counted backward from 
the last exon) in Prof. Chen’s lab [49]. This KO mouse would theoretically have ablated all nesprin-
1 isoforms containing the C-terminal SR region, including nesprin-1α1, nesprin-1α2 and nesprin-
1β. KO litters exhibited over 60% lethality due to muscle weakness leading to feeding 
insufficiency [49]. The surviving KO pups displayed growth retardation and reduced exercise 
capacity, although their heart function was normal [49]. Furthermore, centralised nuclei were 
observed in the KO mouse muscle fibres [49]. Ex vivo analysis showed the expression levels of 
SUN1 and SUN2 were upregulated in heart and skeletal muscle respectively, further confirming 
that nesprin-1 and the LINC complex play essential roles in nuclear positioning [49]. 
 
Nesprin-1α2 KO 
Global nesprin-1α2 KO mice were also generated in Prof. Chen’s lab by floxing the first 
unique exon of nesprin-1α2 and then crossed with Sox2Cre mouse to knockout nesprin-1α2 isoform 
that is highly expressed in skeletal and cardiac muscle [50]. The lethality was high as only 2 out 
of 17 litters survived. At embryonic day 18.5 (E18.5), KO mice remained cyanotic and died within 
5 minutes while WT turned pink and started to breath [50]. Those findings strongly indicate the 
nesprin-1α2 is indispensable for embryonic development. 
Viable KO mice were small with reduced body weight, and developed kyphosis after 
postnatal day 21 (P21), indicating EDMD-like skeletal muscle dysfunction [50]. Nuclei clustering 
was observed in the tibialis anterior (TA) muscle derived from these nesprin-1α2 KO mice at E18.5, 
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which was akin to KASH1 KO② and nesprin-1 C-terminal KO mice [42, 49, 50]. Nesprin-1α2 KO 
samples displayed reduced SUN1 expression and mis-localisation of SUN1 from the NE [50]. 
Surprisingly, the MT motor proteins kinesin-1 including its subunits kinesin light chain-1/2 (KLC-
1/2) and kinesin heavy chain kif5b were also displaced from the NE, supported the notion of 
dynamic myonuclear positioning was governed by muscle specific nesprin isoform nesprin-1α2 
and its association with kinesin-1 in vivo [50].  
 
OTHER NESPRIN MOUSE MODELS 
Nesprin-1/2 mouse models with skin/retina/brain phenotypes 
Nesprin-1 CH KO and Nesprin-2 CH KO 
 Two global nesprin-1/2 N-terminal ABD KO models exist [17, 50]. Nesprin-2 ABD was 
knocked out by deletion of the 2nd - 4th exons of Syne-2 gene encoded for first CH domain in 
nesprin-2 CH KO mice [17]. These mice were well developed, and did not exhibit any skeletal 
muscle or heart defects [17]. However, the epidermis from these global KO mice was thicker but 
did not reveal gross abnormalities [17]. Isolated primary dermal fibroblasts and keratinocytes from 
the KO mice possessed deformed nuclei with unevenly distributed emerin, indicating disrupted 
NE organisation [17]. Unlike nesprin-2 CH KO mice, nesprin-1 CH KO mice were generated by 
floxing the 9th exon, which encodes for the second CH domain of nesprin-1 [50]. These mice 
developed normally without any phenotypes, and the expression levels and localisation of LINC 
complex components were also unchanged [50]. These two different phenotypes could be caused 
by the distinct functions of two CH domains. Nesprin-1 and -2 contain two CH domains (CH1 and 
CH2) juxtaposed at the N-terminus. A single CH2 domain is not able to bind to actin filaments, 
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but it acts as a CH1 enhancer to strengthen the binding with F-actin [51, 52]. Therefore, the 
function of ABD may be partially present in nesprin-1 CH KO, while ABD function was abolished 
in nesprin-2 CH KO mice via depletion of the CH1 domain. 
 
Nesprin-2 KASH KO and Nesprin-1/2 KASH DKO 
The global KASH2 KO mouse line generated by Professor Han’s lab was initially used to 
investigate nuclear positioning in muscle as discussed above [42]. There were no muscle defects 
observed, but a severe reduction of the thickness of the outer nuclear layer in the retina, resulted 
from the mis-localisation of photoreceptor nuclei [48]. Moreover, KASH2 KO mice showed 
reduced response to a maze test and abnormally active responses to new environments, indicating 
a memory and learning defect [45]. In addition, homozygous/heterozygous global nesprin-1/2 
KASH DKO mouse line generated by the same group showed more severe brain phenotypes: a 
smaller brain with enlarged lateral ventricles, inverted layers, loss of other specific cell layers and 
disrupted laminary structure [45]. It is intriguing that similar retinal and neuronal phenotypes were 
also observed in the mice with deletion of both SUN1 and SUN2 [45, 48].  
The three mouse lines above revealed the crucial roles of the LINC complex in retinogenesis 
and neurogenesis: nesprin-1/2, in particular nesprin-2 interacts with SUN1/2 to form the LINC 
complex, connecting nucleus to the centrosome through interactions with MT motor proteins 
dynein/dynactin and kinesin, which regulates dramatic nuclear movement during interkinetic 
nuclear migration and/or nucleokinesis processes that are necessary for proper brain and retina 
development [53-55].  
 
Nesprin-2 (GFP) KASH DN   
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In addition to the 13 nesprin-1/2 mouse models discussed above, Hodzic’s lab generated a 
KASH2 DN mouse strain with insertion of GFP fused to the last 65 amino acids of nesprin-2 
KASH domain [56-58]. It was generated using the Cre/Lox system, which allows targeted 
disruption of endogenous SUN/KASH interactions through the inducible expression of a 
recombinant KASH domain. To date, using this GFP-KASH2 DN mouse line as a genetic tool, 
several LINC complex disruption models were successfully established in a tissue specific manner 
such as cerebellum, retina and skeletal muscle. This strategy bypasses the perinatal lethality and 
potential cell non-autonomous effects of other existing global nesprin-1/2 KO mouse models [38, 
42, 49, 50]. These mice exhibited efficient exogenous KASH2 overexpression, mis-localisation of 
the endogenous nesprin to the endoplasmic reticulum (ER), leading to uncouple the nucleoskeleton 
from the cytoskeleton, which further our understanding of physiological relevance of LINC 
complexes during development and homeostasis in a wide variety of mammalian tissues [57, 58]. 
 
Nesprin-3, Nesprin-4 and KASH5 mouse models 
 Nesprin-3 KO mice were generated via targeted deletion of the 2nd exon, which contains 
the translation start site for both nesprin-3α and nesprin-3β isoforms [59]. These KO mice were 
indistinguishable from WT littermates. There were no overt phenotypes reported [59].  
 Nesprin-4 KO mice were established by replacing the 2nd to 6th exons with an IRES β-gal 
cassette, resulting in an effectively null allele [60]. Loss of nesprin-4 impaired localisation of 
nuclei from the basal to apex in outer hair cells (OHC), leading to progressive hearing loss, 
reproducing phenotype found in deaf patients [60].  
 KASH5 KO mice were generated via targeted deletion of exons 5th-8th, which resulted in a 
premature stop codon, leading to a complete absence of KASH5 [61]. The KASH5 KO mice were 
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phenotypically normal except both male and female were infertile. Testis were much smaller in 
males, whilst the ovaries were barely visible in females [61].  A potential explanation is that 
KASH5 associates with SUN1, indirectly coupling  telomeres with the MT motor protein dynein, 
facilitating efficient homologous chromosome pairing during spermatogenesis [61], thus the 
deficiency of KASH5 would cause the arrest of meiosis, and subsequent infertility.  
 
POSSIBLE MECHANISMS UNDERLYING THE PHENOTYPES OBSERVED IN 
NESPRIN MOUSE MODELS 
 To date, majority of nesprin variants identified in SYNE-1 and SYNE-2 genes have been 
shown to contribute to pathogenesis of muscle diseases including EDMD, DCM, congenital 
muscular dystrophy (CMD), arthrogryposis multiplex congenita (AMC) [12, 29-37, 62] and CNS 
disorders such as ARCA1, autism spectrum disorder and bipolar disorder respectively [63-69]. 
Nesprin-1/2 variants associated with skeletal muscle or cardiac muscle defects are heterozygous 
missense mutations causing amino acid substitutions and mainly localise at the C-terminus of 
SYNE-1/2. In this region, there is a highly conserved fragment with little secondary structure 
named ‘adaptive domain’ (AD). The AD together with SRs in this region help to mediate 
homodimerisation of nesprin proteins and bind to other LINC complex components, including 
lamin A/C and emerin, with high affinity [70, 71]. The AD also plays roles in maintaining 
structural and thermodynamic properties of the nesprin proteins, which has confirmed by thermal 
unfolding tests using circular dichroism and dynamic light scattering [70]. Therefore, these nesprin 
mutations potentially cause defects in structure/flexibility of the functional domains binding to 
lamin A/C, emerin and SUN1/2. In contrast, nesprin-1/2 variants associated with CNS disorders 
are homozygous nonsense mutations, which scatter along SYNE-1/2 genes, especially SYNE-1, 
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resulting in truncation of multiple nesprin isoforms (further details please refer to a recent review 
[72]). These two distinct types of nesprin-1/2 variants may affect tissue specific isoforms of 
nesprin-1 and/or -2 and their associated LINC complexes, leading to tissue specific diseases. In 
addition, only one SYNE-4 mutation causing high-frequency hearing loss was reported in two 
families, which phenotype has been recapitulated in nesprin-4 KO mice [60]. Therefore, most of 
the nesprin mouse models were generated for investigating nesprin-1/2 functions.  
10 out of 14 nesprin-1/2 mouse models exhibited skeletal muscle or cardiac defects 
whereas 2 strains displayed CNS disorders. Although the severity of the phenotypes in affected 
organs/tissues are variable, they all exhibit similar cellular and molecular changes: defects in 
nuclear morphology, nuclear positioning and migration, abnormal localisation and binding of the 
LINC complex proteins SUN1/2, lamin A/C and emerin with nesprin-1/2, indicating a perturbation 
of the LINC complex, similar to those caused by nesprin mutations reported in the patient cells 
with muscle or CNS disorders. These support two principle hypotheses underlying nesprin-related 
diseases: structural disruption and gene dysregulation.  
 
Evidence for structural hypothesis 
Studies on patient tissues/cells carrying nesprin-1/2 mutations revealed structural 
pathological changes. Muscle biopsies derived from EDMD patients carrying nesprin-1/2 
mutations exhibited centralised nuclei with increased variability of fibre size [31, 34]. Further 
studies demonstrated cellular changes with misshapen nuclei, invaginated and detached NE and 
reduced heterochromatin density in EDMD and AMC patient cells carrying nesprin-1/2 mutations 
[12, 37]. In agreement with these observed changes in patient samples, 10 nesprin-1/2 mouse 
models exhibited either mis-positioning of non-synaptic and synaptic nuclei in skeletal muscle or 
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reduced distance between adjacent nuclei, or elongated nuclei in cardiac muscle, whilst 2 strains 
(nesprin-2 KASH KO and nesprin-1/2 KASH DKO) revealed the defect in neuronal migration [29, 
38, 40-42, 49, 50]. Furthermore, LINC complex components lamin A/C, emerin and/or SUN1/2 
were mis-localised from the NE and their interactions with nesprin-1/2 were altered [12, 30, 38, 
40, 50]. The findings strongly suggested nesprin-1/2 mutations cause major disruption in integrity 
of the LINC complex, uncouple the nucleoskeleton from the cytoskeleton, resulted in fragile 
nuclei. This was particularly striking in skeletal and cardiac muscle when subjected to mechanical 
strain, which consequently affect nuclear migration and positioning as these process required 
substantial cytoskeletal forces acting on the nucleus via an intact LINC complex.  
Pioneering insights into function of the LINC complex in nuclear migration and positioning 
came from studying nesprin-1/2 in lower organisms. Depletion of Drosophila nesprin orthologue 
MSP-300 resulted in defective muscle/tendon connections and mis-localised nuclei in oocyte cells 
[73]. Mutations in C. elegans ANC-1, a single giant ONM nesprin orthologue, also led to a muscle 
defect due to disrupted myonuclear migration and decoupled mitochondria from the actin 
cytoskeleton [74]. Indeed, emerging evidence has further revealed that functions of the LINC 
complex in nuclear migration are evolutionary conserved in mammals. In both muscle and CNS, 
nesprin-1/2 act as a hub to assemble the system required for nuclear movement through their 
interactions with SUN1/2 via their KASH domains to form the LINC complex at the NE, and also 
bind to the MT motor proteins dynein/dynactin and kinesin via their SRs [18, 45, 75]. Recently, a 
‘LEWD’ motif at C-terminus of nesprin-1/2 has been identified as a binding region for motor 
proteins kinesin-1 and C-terminal SRs of C. elegans UNC-83, nesprin orthologue, for dynein [18, 
30, 76]. Therefore, nuclei can ‘walk’ bi-directionally along the MT-LINC complex that surrounds 
the NE to achieve precisely nuclear migration and positioning in myoblasts/myotubes and neuronal 
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progenitors/neurons and promote muscle and CNS development [18, 45]. In addition, centrosomal 
proteins Akap450, pericentriolar material-1 (PCM-1) and pericentrin, components of the 
microtubule-organising centre (MTOC), have recently been shown to relocalise to the NE, 
participating in MT nucleation at the initial stage of muscle cell differentiation in a nesprin-1α 
dependent manner [19, 77].  
 
Evidence for gene dysregulation hypothesis 
LINC complex mediates mechanotransduction events, translating biophysical forces into 
biochemical signalling that regulates gene expression. Several studies have now confirmed the 
nesprin giant proteins are subjected to mechanical tension and that physical forces transmitted 
across the LINC complex regulate recruitment of lamin A/C to the INM and emerin 
phosphorylation [78, 79]. These two LINC complex associated components have also been shown 
to anchor chromatin via direct interactions with histones or other chromatin-associated proteins, 
such as heterochromatin protein 1 (HP1) and lamin B receptor (LBR) for lamin A/C and barrier-
to-autointegration factor (BAF) for emerin. These interactions are essential for genome 
arrangement and gene expression [80-83]. Moreover, various transcriptional factors have been 
reported as binding partners for the LINC complex components including extracellular signal–
regulated kinase (ERK) 1/2 and α-catenin for nesprin-2, retinoblastoma protein (pRb), c-fos and 
ERK1/2 for lamin A/C [84-87]. Interestingly, several recent studies demonstrated nesprin 
mutations result in gene dysregulation. Firstly, enhanced ERK1/2 activity was observed in nesprin-
1 KASH KO① heart tissue, fibroblasts derived from EDMD-DCM patients and nesprin-1 mutant 
transfected cells, which might contribute to aberrant activation and expression of downstream 
genes encoding for the components of muscle fibre and sarcomere, thus contributing to muscle 
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dysfunction [30]. Secondly, impaired response to mechanical stress was reported in CMs isolated 
from KASH1/2 DKO mice, which showed completely blunted response in biomechanical genes 
[40]. Finally, either myoblasts derived from EDMD patients or C2C12 myoblasts infected with 
nesprin-1 mutations identified in DCM patients exhibited perturbed myogenesis with less-defined 
myotube structure or reduced expression of myogenic transcriptional factors, such as myoD, 
myogenin and myosin heavy chain [12, 30]. Further investigation is required to elucidate the 
mechanisms between LINC complex disruption and the observed gene dysregulation. 
In summary, both structural and gene regulation hypotheses are not mutually exclusive. It 
is not clear which, if either, is the key trigger. We propose a potential mechanism whereby nesprin 
mutations may fail to build a functional scaffold and/or to maintain chromatin 
compartmentalisation with other LINC complex components such as SUN1/2, emerin and lamin 
A/C, leading to reduced heterochromatin and defective compartmentation; potentially it causes 
defects in initiation of the gene transcription process resulting in decreased or delayed expression 
of the genes encoding proteins that are critical for structural integrity or participating in regulating 
cell activities such as cell differentiation, migration and division, thus accelerating pathogenesis 
and driving the onset of diseases. 
 
CONCLUDING REMARKS 
17 various nesprin mouse models have generated valuable information regarding the roles 
of nesprins and the LINC complex in anchoring the nucleus to cytoskeletal networks, nuclear 
positioning and migration, especially in muscle cells. However, questions regarding how 
disruption of the LINC complex caused by nesprin mutants lead to changes in structural, cell 
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signalling and gene expression, contributing to pathogenesis of nesprin-related diseases remain 
unanswered.  
Further knowledge is required to better understand the diverse spectrum of nesprin 
isoforms. Moreover, full characterisation of tissues or cells derived from patients with EDMD, 
DCM or ARCA1 etc., and introduced pluripotent stem cells (iPSC) will help to decipher the roles 
of nesprins in developmental cell fate and physiological functions of disease-relevant cells [88]. 
Furthermore, in contrast to current nesprin mouse models with deletion or overexpression of 
functional domains (KASH domains, C-terminal SRs and CH domains), more clinically relevant 
mouse models could be generated to recapitulate the human conditions via CRISPR Cas9 genome 
edited knock-in mouse lines, or focus on functional studies on tissue specific nesprin isoforms 
such as nesprin-1α2, 2α1 and 2Ɛ2 in heart and skeletal muscle, and two nesprin-1 KASH-less 
isoforms in brain [9, 49, 89]. In addition, whole genome or single cell microarray analysis could 
be performed on cells isolated from these models to explore the expression profiles of dysregulated 
genes and associated signalling pathways. These approaches would potentially help uncover how 
dysfunction of nesprins and the LINC complex contribute to pathogenesis of nesprin-related 
diseases and provide information on establishing therapeutic targets for these disorders. 
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FIGURE LEGENDS 
Figure 1. Nesprin-1/2 mouse models 
Various nesprin-1/2 mouse models were generated via targeting to different regions of Syne-1 and 
Syne-2 genes. The colours indicate different research groups who generated the models (Red - 
Noegel A. [17]; Blue - Han M.[41, 42]; Violet - McNally, E. M. [38]; Green - Chen J. [40, 49, 50]; 
Grey – Hodzic D. [57]. Nesprin-1/2 KASH DKO mice were generated via breeding nesprin-1 
KASH KO② with nesprin-2 KASH KO (Han group) [42]. Nesprin-1/2 C-terminal DKO mice were 
independently generated via crossing two established mouse lines: cardiac specific nesprin-1 C-
terminal KO and nesprin-2 C-terminal KO (Chen group) [40]. KO: knockout; DKO: double 
knockout; DN: dominant negative; csNesprin-1 C-terminal KO: cardiac specific Nesprin-1 C-
terminal KO.  
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Table 1: Summarisation of nesprin mouse models 
Gene Mice Targeted 
region 
Targeted 
tissue 
Strategy 
 
Affected 
organs 
Phenotypes and/or cellular changes Ref. 
S
yn
e-
1
 
Nesprin-1 
KASH KO
①
 
KASH 
domain 
 
Global Floxed deletion of the last exon of Syne-1 
resulting in the deletion of last two exons (~100 
residues, including KASH domain) and inserted 
additional 61 amino acids without homology to 
any known proteins 
Heart  
Skeletal muscle 
 
 49% new born litters died due to respiratory failure; 
 Rest of pups survived up to 1 year and developed heart 
conduction defect with left ventricle (LV) systolic dysfunction; 
 Smaller muscle fibres with mis-positioned nuclei; 
 Kyphoscoliosis. 
[29, 38] 
Nesprin-1 
KASH DN 
Skeletal and 
cardiac 
Overexpression of the last 344 amino acid (SR74 
to KASH domain) of Syne-1 under a muscle 
creatine kinase (MCK) promoter 
Skeletal muscle  No overt phenotype reported; 
 In muscle fibre, synaptic nuclei failed to aggregate at the 
neuromuscular junction (NMJ). 
[41] 
Nesprin-1 
KASH KO
②
 
Global Targeted deletion of the last exon of Syne-1, 
including KASH domain 
Skeletal muscle  No external phenotype reported; 
 In muscle fibre, synaptic nuclei completely lost at the NMJ, 
non-synaptic nuclei formed clusters or arrays. 
[42] 
Nesprin-1 C-
terminal KO 
C-terminus 
 
Global Floxed deletion of the 16th exon of Syne-1 
resulting in a premature stop codon at the 13th 
exon (counted backward from the last exon), 
which ablated all nesprin-1 isoforms containing 
the C-terminal SRs region with or without KASH 
domain 
Skeletal muscle 
 
 Over 60% mice died prenatally due to feeding insufficiency 
caused by muscle weakness; 
 In muscle fibres: mis-positioned nuclei and disrupted nuclei 
anchorage; 
 Reduced exercise capacity; 
 Normal heart function. 
[49] 
Cardiac 
Nesprin-1 C-
terminal KO 
Cardiac Crossing the Syne-1 KO mice [48] with 
Nkx2.5Cre to KO nesprin-1 C-terminus 
containing isoforms in heart 
Heart  No overt cardiac functional defect;  
 Isolated cardiomyocytes showed changed nuclear morphology 
and perturbed mechanotransduction response. 
[40] 
Nesprin-1 
CH KO 
CH domain Global Floxed exon 9, encoding for the 2nd CH domain 
in Syne-1 and crossed with Sox2Cre mice to 
globally ablate expression of nesprin-1 CH 
domain containing isoforms 
None  Survived up to 18 months;  
 No overt phenotypes reported. 
[50] 
Nesprin-1α2 
KO 
Isoform 
specific  
 
Global Floxed first exon which is unique to nesprin-1α2, 
then crossed with Sox2Cre mice to globally 
ablate expression of nesprin-1α2 
Skeletal muscle  12% of litters survived;  
 In muscle fibres: nuclei were mis-positioned due to loss the 
interaction between nesprin-1α2 and microtubule motor protein 
kinesin-1. 
[50] 
S
yn
e-
2
 
Nesprin-2 
KASH DN 
KASH 
domain 
 
Skeletal and 
cardiac 
Overexpression of 183 amino acids of KASH 
containing domain of Syne-2 under the MCK 
promoter  
Skeletal muscle  No external phenotype reported; 
 In muscle fibres, synaptic nuclei failed to aggregate at the NMJ. 
[42] 
Nesprin-2 
(GFP) KASH 
DN 
Reporter 
mouse to be 
induced by 
crossing 
with tissue 
specific Cre 
Overexpression of GFP fused to last 65 amino 
acids of KASH containing domain of Syne-2 
using the Cre/Lox system, thus DN KASH2 can 
be expressed under a tissue specific promoter 
Retina 
Brain 
Skeletal muscle 
(due to tissue 
specific 
expression) 
 In retina: nuclei mis-localised on the basal side of the outer 
nuclear layer 
 In Purkinje cells and skeletal muscle: exogenous EGFP-KASH2 
was efficiently expressed, leading to mis-localised endogenous 
nesprin-1 and -2. 
[56-58] 
Nesprin-2 
KASH KO 
 
Global Targeted deletion of the last two exons of Syne-2 
including KASH domain 
 
Retina 
Brain 
 In retina: thinner outer nuclear layer, electrophysiological 
dysfunction, mis-localisation of photoreceptor nuclei and 
defects in photoreceptor cell migration;  
 Defects in learning and memory due to the disrupted laminary 
structures. 
[42, 45, 
48] 
Nesprin-2 C-
terminal KO 
C-terminus 
 
Global Floxed deletion of the 7th exon of Syne-2 
(counted backward from the last exon), targeted 
to delete all nesprin-2 isoforms containing the C-
terminal SRs region with or without KASH 
domain 
Heart  Survived up to 18 months; 
 Isolated cardiomyocytes showed changed nuclear morphology 
and perturbed mechanotransduction response. 
[40] 
Nesprin-2 
CH KO 
CH domain 
 
Global Targeted deletion of the 2nd - 4th exons of Syne-2 
gene encoding the first CH domain 
Skin  In skin: thicker epidermis, increased epithelial nuclear size and 
heavily misshaped nuclei 
[17] 
S
yn
e-
1
/2
 
Nesprin-1/2  
C-terminal 
DKO 
C-terminus Global  
(nesprin-2 
KO) & 
Cardiac 
(nesprin-1 
KO) 
Crossing the cardiac specific nesprin-1 C-
terminal KO mice with the global nesprin-2 C-
terminal KO mice  
Heart  Reduced LV wall thickness, LV systolic dysfunction, increased 
fibrosis and apoptosis; 
 Changed nuclear morphology, reduced density of 
heterochromatin, altered nuclear positioning and impaired 
mechanotransduction response. 
[40] 
Nesprin-1/2 
KASH DKO 
KASH 
domain 
 
Global Crossing the KASH1 KO
②
 mice (deletion of the 
last exon of Syne-1) with KASH2 KO mice 
(deletion of the last two exons of Syne-2) 
Skeletal muscle 
Brain 
 New born litters failed to breath and died shortly after birth;  
 In muscle fibres: the synaptic-nuclei number were absent in the 
NMJ; 
 In brain: smaller brain with enlarged lateral ventricles, inverted 
layers, loss of other specific cell layers and disrupted laminary 
structure 
[42, 45] 
S
yn
e-
3
/4
 &
 K
A
S
H
5
 
Nesprin-3 
KO 
Nesprin-3 Global Targeted deletion of the 2nd exon of Syne-3, 
which contains the translation starting site for 
both nesprin-3α and nesprin-3β isoforms 
None  No overt phenotype reported.  [59] 
Nesprin-4 
KO 
Nesprin-4 Global Replacement of the 2nd to 6th exons with an IRES 
β-gal cassette, resulting in an effectively null 
allele 
Ear  Impaired the localisation of nuclei from the basal to apex in 
outer hair cells, leading to progressed hearing loss.  
[60] 
KASH5 KO KASH5 Global Targeted deletion of 5th - 8th exons which resulted 
in a premature stop codon, leading to a complete 
absence of KASH5 
Reproductive 
system 
 Defects of homologous chromosome pairing during 
spermatogenesis, resulting in infertility. 
[61] 
KO: knockout; DKO: double knockout; DN: dominant negative. 
Nesprin-1 KASH KO
①
: the nesprin-1 KASH KO mouse model generated in Prof. McNally’s lab; 
Nesprin-1 KASH KO
②
: the nesprin-1 KASH KO mouse model generated in Prof. Han’s lab. 
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